Insider activity · JNJ · Healthcare

Johnson & Johnson (JNJ) insider filing adds an executive acquisition

The update gives investors a fresh ownership datapoint as the drugmaker is viewed through weekly market data rather than live intraday action.

Johnson & Johnson
Latest240.87 USD
1W move3.5%
Volume1.0x
TrendActive
Pharmaceutical lab and medicine packaging line representing Johnson & Johnson market coverage.

Market update

What happened

Johnson & Johnson (JNJ) reported insider activity dated June 11 for Kathryn E. Wengel, EVP, Chief TO and Risk Officer. The filing listed an acquisition of 10,000 common shares at 115.67 USD per share.

The stock’s weekly setup is constructive on price but not one-way. The trend screen remains active and Relative Strength is 7.9, while Market Dynamics shows pressure at -0.79.

Continue your research

Explore JNJ across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

JNJ coverage

Evidence context